Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Nunez

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
World Neurosurgery|July 1, 2018
Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial TumorsJacob S Young, Giovanna Bernal, Sean P Polster, et al.
La Radiologia Medica|September 30, 2025
Association between type of skull base osteomyelitis (SBO), source, and infection spread in patients with proven SBODavid Timaran Montenegro, Kamand Khalaj, Elham Tavakkol, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 13, 2025
Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurementsDavid Timaran-Montenegro, Luis Nunez, Antonio Dono, et al.
European Journal of Clinical Nutrition|September 4, 2023
Exocrine pancreatic insufficiency following bariatric surgery: unveiling alternative aetiology-case report and short reviewCamila Milad, Jorge Luis Nunez-Pizarro, Ainitze Ibarzábal, et al.
Medical Physics|April 10, 2012
Correction factors for A1SL ionization chamber dosimetry in TomoTherapy: machine-specific, plan-class, and clinical fieldsAraceli Gago-Arias, Ruth Rodriguez-Romero, Patricia Sanchez-Rubio, et al.
Journal of Neuro-Oncology|February 13, 2024
Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtypeAntonio Dono, Jose Torres, Luis Nunez, et al.
The Neuroradiology Journal|August 3, 2025
IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation statusKamand Khalaj, Elham Tavakkol, Luis Nunez, et al.
Frontiers in Neuroimaging|November 10, 2025
A Bayesian deep segmentation framework for glioblastoma tumor segmentation using follow-up MRIsTanjida Kabir, Kang-Lin Hsieh, Luis Nunez, et al.
Journal of Neuro-Oncology|July 11, 2022
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomasYoko Fujita, Luis Nunez-Rubiano, Antonio Dono, et al.
Cancer Research|March 27, 2015
Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of TemozolomideNassir M Mansour, Giovanna M Bernal, Longtao Wu, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
World Neurosurgery|July 1, 2018
Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial TumorsJacob S Young, Giovanna Bernal, Sean P Polster, et al.
La Radiologia Medica|September 30, 2025
Association between type of skull base osteomyelitis (SBO), source, and infection spread in patients with proven SBODavid Timaran Montenegro, Kamand Khalaj, Elham Tavakkol, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 13, 2025
Glioblastoma IDH-wild type: imaging independent predictors of gross total resection (GTR) using the VASARI feature set and tumoral volumetric measurementsDavid Timaran-Montenegro, Luis Nunez, Antonio Dono, et al.
European Journal of Clinical Nutrition|September 4, 2023
Exocrine pancreatic insufficiency following bariatric surgery: unveiling alternative aetiology-case report and short reviewCamila Milad, Jorge Luis Nunez-Pizarro, Ainitze Ibarzábal, et al.
Medical Physics|April 10, 2012
Correction factors for A1SL ionization chamber dosimetry in TomoTherapy: machine-specific, plan-class, and clinical fieldsAraceli Gago-Arias, Ruth Rodriguez-Romero, Patricia Sanchez-Rubio, et al.
Journal of Neuro-Oncology|February 13, 2024
Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtypeAntonio Dono, Jose Torres, Luis Nunez, et al.
The Neuroradiology Journal|August 3, 2025
IDH wild-type glioblastoma: Predictive value of standard-of-care (SOC) MRI for establishing MGMT promoter methylation statusKamand Khalaj, Elham Tavakkol, Luis Nunez, et al.
Frontiers in Neuroimaging|November 10, 2025
A Bayesian deep segmentation framework for glioblastoma tumor segmentation using follow-up MRIsTanjida Kabir, Kang-Lin Hsieh, Luis Nunez, et al.
Journal of Neuro-Oncology|July 11, 2022
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomasYoko Fujita, Luis Nunez-Rubiano, Antonio Dono, et al.
Cancer Research|March 27, 2015
Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of TemozolomideNassir M Mansour, Giovanna M Bernal, Longtao Wu, et al.
Pageof 3